Antimalarial Medications
- PMID: 29261925
- Bookshelf ID: NBK470158
Antimalarial Medications
Excerpt
When treating patients suspected of having malaria, it is essential that treatment does not commence until the diagnosis of malaria has been established. The obvious exception is in waiting for confirmation to treat suspected malaria if the patient shows signs of severe malaria, and clinical suspicion for malaria is high. This activity reviews the indications, contraindications, adverse events, and other key elements of antimalarial therapy in the clinical setting related to the essential points needed by members of an interprofessional team managing the care of patients with a malarial infection require treatment.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Nahhas AF, Braunberger TL, Hamzavi IH. An Update on Drug-Induced Pigmentation. Am J Clin Dermatol. 2019 Feb;20(1):75-96. - PubMed
-
- Mvango S, Matshe WMR, Balogun AO, Pilcher LA, Balogun MO. Nanomedicines for Malaria Chemotherapy: Encapsulation vs. Polymer Therapeutics. Pharm Res. 2018 Oct 15;35(12):237. - PubMed
-
- Naß J, Efferth T. The activity of Artemisia spp. and their constituents against Trypanosomiasis. Phytomedicine. 2018 Aug 01;47:184-191. - PubMed
-
- Pinheiro LCS, Feitosa LM, Silveira FFD, Boechat N. Current Antimalarial Therapies and Advances in the Development of Semi-Synthetic Artemisinin Derivatives. An Acad Bras Cienc. 2018;90(1 Suppl 2):1251-1271. - PubMed
Publication types
LinkOut - more resources
Full Text Sources